Biktarvy

Bictegravir Sodium,

Emtricitabine,

Tenofovir Alafenamide Fumarate

4.5 Moderate risk

Biktarvy & Weight increased

12.2%

of users reported Weight increased

83.9%

also reported Severe reaction

60.6%

are men

Most common medical consequences

Severe reaction

83.9%

Disability

10.7%

Hospitalization

5.4%

Have you experienced any negative side effects from this medication?

Biktarvy: general information

Most common side effects (70)

Most commonly affected ages

10 - 19 years

0.6%

20 - 29 years

11.4%

30 - 39 years

18.9%

40 - 49 years

22.1%

50 - 59 years

25.7%

60 - 69 years

19.4%

70 - 79 years

1.9%

On this page